The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
936
November 25, 1994
View Complete Issue         Table of Contents 2019 
Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
November 25, 1994 (Issue: 936)
A drug that combines the neutral sulfate salts of dextroamphetamine and racemic amphetamine with the dextro isomer of amphetamine saccharate and d,l amphetamine aspartate (Adderall - Richwood Pharmaceutical) has recently been promoted for treatment...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
Article code: 936b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.